Accuracy of QT(c) and QTI for detection of autonomic dysfunction

Annals of Noninvasive Electrocardiology

Volumn 4, Issue 3, 1999, Pages 257-266

  Whitsel, Eric A ^a,c   Boyko, Edward J ^a   Siscovick, David S ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c Veterans Affairs Puget Sound   (United States)

Author keywords

Accuracy; Autonomic neuropathy; Diagnosis; QT; Systematic review

Indexed keywords

ADRENERGIC NERVE; ADULT; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; AUTONOMIC NEUROPATHY; CARDIOVASCULAR REFLEX; DIAGNOSTIC ACCURACY; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE VARIABILITY; HUMAN; LIGAND BINDING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QT INTERVAL; SINUS RHYTHM;

EID: 0032844085     PISSN: 1082720X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1542-474X.1999.tb00209.x     Document Type: Article

References (43)

1. Bazett HC. An analysis of the time-relations of electrocardiograms, Heart 1920;7:353-370.
2. Taran LM., Szilagyi N. The duration of electrical systole (Q-T) in acute rheumatic carditis in children. Am Heart J 1947;33:14-26.
3. Stern S, Eisenberg S. The effect of propranolol (Inderal) on the electrocardiogram of normal subjects. Am Heart J 1969;77:192-195.
4. Seides SF., Josepheson ME., Batsford WP., et al. The electrophysiology of propranolol in man. Am Heart J 1974;88:733-741.
5. Milne JR., Camm AJ., Ward DE, et al. Effect of intravenous propranolol on QT interval: A new method of assessment. Br Heart J 1980:43:1-6.
6. Edvardsson N, Olsson SB. Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man. Br Heart J 1981;45:628-636.
7. Browne KF, Zipes DP, Heger JJ, et al. Influence of the autonomic nervous system on the Q-T interval in man. Am J Cardiol 1982;50;1099-1103.
8. Cappato R, Alboni P, Pedroni P, et al. Sympathetic and vagal influences on rate-dependent changes of QT interval in healthy subjects. Am J Cardiol 1991;68:1188-1193.
9. Ewing DJ, Martyn CN, Young RY, et al. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care 1985;8:491-498.
10. Gonin JM, Kadrofske MM, Schmaltz S, et al. Corrected Q-T interval prolongation as diagnostic tool for assessment of cardiac autonomic neuropathy in diabetes mellitus. Diabetes Care 1990;13:68-71.
11. Veglio M, Maule S, Matteoda C, et al. Use of the corrected QT interval in autonomic function testing: Assessment of reproducibility. Clin Auton Res 1996;6:309-312.
12. Kahn R. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomic nervous system testing. Diabetes Care 1992:15:1095-1103 and Neurology 1992;42:1831-1837.
13. Kahn R. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Autonomic nervous system testing. Diabetes Care 1992:15:1095-1103 and Neurology 1992;42:1831-1837.
14. Kahn JK, Sisson JC, Vinik AI. QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J Clin Endocrinol Metab 1987;64:751-754.
15. Chambers JB, Sampson MJ, Sprigings DC, et al. QT prolongation on the electrocardiogram in diabetic autonomic neuropathy. Diabetic Med 1990;7:105-110.
16. Sivieri R, Veglio M, Chinaglia P, et al. Prevalence of QT prolongation in a type 1 diabetic population and its association with autonomic neuropathy. Diabetic Med 1993;10:920-924.
17. Lo SSS, Sutton MSJ, Leslie DG. Information on type 1 diabetes mellitus and QT interval from identical twins. Am J Cardiol 1993;72:305-309.
18. c interval measure versus standardized tests in diabetic autonomic neuropathy. Diabetic Med 1995;12:302-306.
19. max and QT rate sensitivity. Computers and Biomedical Research 1993;26:188-204.
20. Ewing DJ, Campbell IW, Clarke BF. Heart rate changes in diabetes mellitus. Lancet 1981;1:183-186.
21. Rautaharju PM, Zhou SH, Wong S, et al. Sex differences in the evolution of the electrocardiographic QT interval with age. Can J Cardiol 1992;8:690-695.
22. Rautaharju PM, Warren JW, Calhoun HP. Estimation of QT prolongation. A persistent, avoidable error in computer electrocardiography. J Electrocardiol 1991;23S:111-117.
23. Ahnve S, Vallin H. Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation 1982;65:435-439.
24. Zhou SH, Wong S, Rautaharju PM, et al. Should the JT rather than the QT interval be used to detect prolongation of ventricular repolarization? An assessment in normal conduction and in ventricular conduction defects. J Electrocardiol 1992;25S:131-136.
25. c intervals after acute myocardial infarction. Acta Med Scand 1980;208:223-228.
26. Nyberg G, Vedin A, Wilhelmsson C. QT time in patients treated with alprenolol or placebo after myocardial infarction. Br Heart J 1979;41:452-455.
27. Jose AD, Collison D. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res 1970;4:160-167.
28. Littenberg B, Moses LE. Estimating diagnostic accuracy from multiple conflicting reports: A new meta-analytic method. Med Decis Making 1993;13:313-321.
29. Irwig L, Tosteson ANA, Gatsonis C, et al, Guidelines for meta-analyses evaluating diagnostic tests. Ann Intern Med 1994;120:667-676.
30. Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: Issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996;15:361-387.
31. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
32. Coughlin SS, Trock B, Criqui MH, et al. The logistic modelling of sensitivity, specificity, and predictive value of a diagnostic test. J Clin Epidemiol 1992;45:1-7.
33. Schwartz PJ, Moss AJ, Vincent GM, et al. Diagnostic criteria for the long QT syndrome. An update. Circulation 1993;88:782-784.
34. Rautaharju PM, Manolio TA, Psaty BM, et al. Correlates of QT prolongation in older adults (the Cardiovascular Health Study). Am J Cardiol 1994;73:999-1002.
35. K'aldor A, Gach'alyi B, Szigeti A, et al. "Intrinsic" heart rate in diabetic neuropathy. Int J Clin Pharm Biopharm 1977;15:335-336.
36. Fleming TR, DeMets DL. Surrogate endpoints in clinical trials: Are we being misled? Ann Intern Med 1996;125:605-613.
37. Cowan JC, Yusoff K, Moore M, et al. Importance of lead selection in QT interval measurement. Am J Cardiol 1988;61:83-87.
38. Report and recommendations of the San Antonio Conference on Diabetic Neuropathy. Diabetes Care 1988;11:592-597.
39. Dickersin K, Min YI. Publication bias: The problem that won't go away. Ann N Y Acad Sci 1993;703:135-146.
40. Colditz GA, Miller JN, Mosteller F. How study design affects outcome in comparisons of therapy. I: Medical. Stat Med 1989;8:441-454.
41. Wortman PM. Judging research quality. In H Cooper, LV Hedges (eds.): The Handbook of Research Synthesis. New York, Russell Sage Foundation, 1994, pp. 97-109.
42. Moher D, Fortin P, Jadad AR, et al. Completeness of reporting of trials published in languages other than English: Implications for conduct and reporting of systematic reviews. Lancet 1996;347:363-366.
43. Grégoire G, Derderian F, Le Lorier J. Selecting the language of the publications included in a meta-analysis: Is there a Tower of Babel bias? J Clin Epidemiol 1995;48:159-163.